Brain degenerative disorders such as Alzheimer's disease (AD) can be exacerbated by
aberrant metabolism. Supplementation with probiotic bacteria is emerging as a promising …

Aging and metabolic syndrome are associated with neurodegenerative pathologies
including Alzheimer's disease (AD) and there is growing interest in the prophylactic potential …

The steadily increasing prevalence of Alzheimer's disease (AD) worldwide and the lack of
effective therapeutic agent attract novel therapeutic approach in recent years. In view of the …

Objective: The role of gut microbiota in the pathogenesis of several neurodegenerative
disorders, including Alzheimer's disease (AD), via the gut–brain axis has recently been …

Background & aims Alzheimer's disease (AD) and age-related dementias represent a major
and increasing global health challenge. Unhealthy diet and lifestyle can unbalance the …

Gut microbiota has a proven role in regulating multiple neuro-chemical pathways through
the highly interconnected gut-brain axis. Oral bacteriotherapy thus has potential in the …

Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease that
results in gradual cognitive impairment and eventually leads to dementia. However, despite …

The gastrointestinal microbiota affects brain function, including memory and learning. In this
study we investigated the effects of probiotics on memory and oxidative stress biomarkers in …

Alzheimer's disease (AD) is a global public health priority as with aging populations, its
prevalence is expected to rise even further in the future. The brain and gut are in close …

The gut brain axis seems to modulate various psychiatric and neurological disorders such
as Alzheimer's disease (AD). Growing evidence has led to the assumption that the gut …